StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) KPIs and segments

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$15.34−0.80 (-4.99%)

Close on Nov 16, 2026Market cap $975.27MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Jade Biosciences's business

Coming soon

This tab will track the numbers specific to Jade Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?